Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Daiichi Sankyo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Daiichi Sankyo's 2012 sales performance.

Daiichi Sankyo

FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis

FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis

Other directly-acting or ‘novel orally acting anticoagulants’ (NOACs) include Bayer/Johnson &Johnson's Xarelto (rivaroxaban) and Daiichi Sankyo's Lixiana/Savaysa – which like Eliquis are Factor Xa inhibitors – and Boehringer

AZ, Daiichi Sankyo get early okay for DS-8201, now named Enhertu

AZ, Daiichi Sankyo get early okay for DS-8201, now named Enhertu The US approval sparks a $125m payment to Daiichi Sankyo from AZ – the first milestone payment in the alliance. ... Sales of Enhertu in the US will be booked by Daiichi Sankyo with AZ claiming a share of gross profits.

EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla

EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla Among the rivals is Daiichi Sankyo and AstraZeneca’s  trastuzumab deruxtecan (DS-8201), another ADC currently under regulatory review for patients with advanced HER2-positive breast cancer that have failed Kadcyla

AZ, Daiichi Sankyo strengthen case for HER2 candidate

AZ, Daiichi Sankyo strengthen case for HER2 candidate Will rival Roche's HER2 franchise if approved. AstraZeneca’s big bet on a Daiichi Sankyo-developed HER2-targeting antibody-drug conjugate looks like its about to pay off, after delivering ... AZ and Daiichi Sankyo are looking at a possible approval for

Seattle Genetics moves to dismiss ADC lawsuit with Daiichi Sankyo

Seattle Genetics moves to dismiss ADC lawsuit with Daiichi Sankyo US-based biotech is arguing the legal action is improper. Seattle Genetics has asked a court to dismiss a lawsuit brought a few weeks ago by Japan’s Daiichi Sankyo centring ... The two companies previously collaborated on ADC drug development between

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...
White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...

Infographics